Vaccine researchers are trying new tacks in an unprecedented effort to recruit the tens of thousands of healthy volunteers needed to finish testing coronavirus shots in late stages of development.

Quickly lining up all the subjects for so many studies at the same time poses several challenges, creating competition among companies.